Digital Pathology Services
Advanced Pathology Services for Fast, Reliable Data: Histopathology, IHC, IF, and In Situ Hybridization with Automated Precision
2024-12-05
2024-03-17
At Crown Bioscience, our Patient-Derived Xenograft (PDX) Tumor Microarrays (TMAs) offer researchers a powerful tool for cancer research, enabling high-throughput analysis of various cancer types. Our PDX TMAs provide an extensive array of tissue samples crucial for biomarker validation, drug target discovery, and translational research.
For more information about our PDX TMAs or to discuss your research needs, please contact us.
Advanced Pathology Services for Fast, Reliable Data: Histopathology, IHC, IF, and In Situ Hybridization with Automated Precision
Explore the complete transcriptome and over 570 protein targets individually or in tandem, utilizing a range of sample inputs including whole tissue sections, tissue microarrays (TMAs), or organoids.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy